Aptahem’s collaboration with Örebro University defines a previously not shown unique modulation mechanism on coagulation and inflammation from Apta-1
Aptahem can today announce that further studies with Örebro University on Apta-1 show strong evidence in its features on the coagulation and inflammation by a unique modulation of Thrombin. This mechanism of action distinctly differs from current clinical used thrombin inhibitor drugs.The Cardiovascular Research Centre at Örebro University and Aptahem research teams have with these clarifying data added a conclusive understanding to one of Apta-1’s unique mechanisms. Background information to give a better understanding of the unique impact on coagulation and inflammation by a new potent